Literature DB >> 10357819

The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.

J Yie1, M Merika, N Munshi, G Chen, D Thanos.   

Abstract

Transcriptional activation of the virus inducible enhancer of the human interferon-beta (IFN-beta) gene in response to virus infection requires the assembly of an enhanceosome, consisting of the transcriptional activators NF-kappaB, ATF-2/c-Jun, IRFs and the architectural protein of the mammalian high mobility group I(Y) [HMG I(Y)]. Here, we demonstrate that the first step in enhanceosome assembly, i.e. HMG I(Y)-dependent recruitment of NF-kappaB and ATF-2/c-Jun to the enhancer, is facilitated by discrete regions of HMG I and is mediated by allosteric changes induced in the DNA by HMG I(Y) and not by protein-protein interactions between HMG I(Y) and these proteins. However, we show that completion of the enhanceosome assembly process requires protein-protein interactions between HMG I(Y) and the activators. Finally, we demonstrate that once assembled, the IFN-beta enhanceosome is an unusually stable nucleoprotein structure that can activate transcription at high levels by promoting multiple rounds of reinitiation of transcription.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357819      PMCID: PMC1171389          DOI: 10.1093/emboj/18.11.3074

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

Review 1.  High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.

Authors:  M Bustin; R Reeves
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1996

2.  High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters.

Authors:  S R Himes; L S Coles; R Reeves; M F Shannon
Journal:  Immunity       Date:  1996-11       Impact factor: 31.745

3.  The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif.

Authors:  J R Huth; C A Bewley; M S Nissen; J N Evans; R Reeves; A M Gronenborn; G M Clore
Journal:  Nat Struct Biol       Date:  1997-08

4.  Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter.

Authors:  J Yie; S Liang; M Merika; D Thanos
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  Oct-1 POU domain-DNA interactions: cooperative binding of isolated subdomains and effects of covalent linkage.

Authors:  J D Klemm; C O Pabo
Journal:  Genes Dev       Date:  1996-01-01       Impact factor: 11.361

6.  Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7.

Authors:  M Sato; N Hata; M Asagiri; T Nakaya; T Taniguchi; N Tanaka
Journal:  FEBS Lett       Date:  1998-12-11       Impact factor: 4.124

7.  Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y).

Authors:  J V Falvo; D Thanos; T Maniatis
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

8.  Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome.

Authors:  D Thanos; T Maniatis
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

9.  Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains.

Authors:  H R Ashar; M S Fejzo; A Tkachenko; X Zhou; J A Fletcher; S Weremowicz; C C Morton; K Chada
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

10.  Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours.

Authors:  E F Schoenmakers; S Wanschura; R Mols; J Bullerdiek; H Van den Berghe; W J Van de Ven
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

View more
  54 in total

1.  An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV 18 transcription.

Authors:  I Bouallaga; S Massicard; M Yaniv; F Thierry
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

Review 2.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

3.  Target Explorer: An automated tool for the identification of new target genes for a specified set of transcription factors.

Authors:  Alona Sosinsky; Christopher P Bonin; Richard S Mann; Barry Honig
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Construction and analysis of cells lacking the HMGA gene family.

Authors:  Brett Beitzel; Frederic Bushman
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

5.  DNA-binding domain of GCN4 induces bending of both the ATF/CREB and AP-1 binding sites of DNA.

Authors:  Anatoly I Dragan; Yingyun Liu; Elena N Makeyeva; Peter L Privalov
Journal:  Nucleic Acids Res       Date:  2004-09-30       Impact factor: 16.971

6.  DNA binding mediated by the wheat HMGa protein: a novel instance of selectivity against alternating GC sequence.

Authors:  Y L Chua; K H Pwee; R M Kini; C Y Leng; P K Hock
Journal:  Plant Mol Biol       Date:  2001-05       Impact factor: 4.076

7.  Mechanism by which the IFN-beta enhanceosome activates transcription.

Authors:  J Yie; K Senger; D Thanos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

8.  Bypassing the requirements for epigenetic modifications in gene transcription by increasing enhancer strength.

Authors:  George Koutroubas; Menie Merika; Dimitris Thanos
Journal:  Mol Cell Biol       Date:  2007-11-19       Impact factor: 4.272

9.  A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity.

Authors:  Daniela Bosisio; Ivan Marazzi; Alessandra Agresti; Noriaki Shimizu; Marco E Bianchi; Gioacchino Natoli
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

10.  HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity.

Authors:  Isabelle Bouallaga; Sébastien Teissier; Moshe Yaniv; Françoise Thierry
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.